The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusion

    Authors

    J. Althaus; M. D. Siegelin; F. Dehghani; L. Cilenti; A. S. Zervos;A. Rami

    Comments

    Authors: contact us about adding a copy of your work at STARS@ucf.edu

    Abbreviated Journal Title

    Neurochem. Int.

    Keywords

    serme protease Omi/HtrA2; ischemia; apoptosis; ucf-101; neuroprotection; APOPTOSIS PROTEINS; DNA FRAGMENTATION; RAT HIPPOCAMPUS; GENE-TRANSFER; INHIBITOR; ISCHEMIA; CASPASE; SMAC/DIABLO; HTRA2; IDENTIFICATION; Biochemistry & Molecular Biology; Neurosciences

    Abstract

    Omi/HtrA2 is a pro-apoptotic mitochondrial serine protease involved in both forms of apoptosis, caspase-dependent as well as caspaseindependent cell death. However, the impact of Omi/HtrA2 in the apoptotic cell machinery that takes place in vivo under pathological conditions such as cerebral ischemia remains unknown. The present study was monitored in order to examine whether Omi/HtrA2 plays a decisive role in apoptosis observed after focal cerebral ischemia in rats. Male adult rats were subjected to 90 min of focal cerebral ischemia followed by reperfusion and treated with vehicle or ucf-101, a novel and specific Omi/HtrA2 inhibitor, prior reperfusion. Focal cerebral ischemia/reperfusion induced a mitochondrial up-regulation of Omi/HtrA2 and significantly increased cytosolic accumulation of Omi/HtrA2. Furthermore, ischemia led to activation of caspase-3 and degradation X-linked inhibitor of apoptosis protein (XIAP). Treatment of animals prior ischemia with ucf-101, the specific inhibitor of Omi/HtrA2, was able to (1) reduce the number of TUNEL-positive cells, to (2) attenuate the XIAP-breakdown and to (3) reduce the infarct size. This study shows for the first time that focal cerebral ischemia in rats results in Omi/HtrA2 translocation from the mitochondria to the cytosol, where it participates in neuronal cell death. Blocking the proteolytic activity of Omi/HtrA2 with specific inhibitors, such as the ucf-101, could be a novel way to afford neuroprotection and minimize cellular damage in cerebral ischemia/reperfusion. (c) 2006 Elsevier Ltd. All rights reserved.

    Journal Title

    Neurochemistry International

    Volume

    50

    Issue/Number

    1

    Publication Date

    1-1-2007

    Document Type

    Article

    Language

    English

    First Page

    172

    Last Page

    180

    WOS Identifier

    WOS:000243645000019

    ISSN

    0197-0186

    Share

    COinS